U.S. RESEARCH ROUNDUP-BTCS, Gevo, ServiceNow

Reuters12-24 22:46

Dec 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BTCS, Gevo and ServiceNow, on Tuesday.

HIGHLIGHTS

* Brookline Bancorp Inc : KBW cuts to market perform from outperform

* BTCS Inc : H.C. Wainwright raises target price to $5 from $3

* Gevo Inc : Jefferies raises target price to $1.4 from $0.6

* ServiceNow Inc : Raymond James initiates coverage with outperform rating

* Vertex Pharmaceuticals Inc : Truist Securities cuts PT to $460 from $550

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

* Berkshire Hills Bancorp Inc : KBW raises target price to $34.50 from $32

* Brookline Bancorp Inc : KBW cuts to market perform from outperform

* BTCS Inc : H.C. Wainwright raises target price to $5 from $3

* Enanta Pharmaceuticals Inc : H.C. Wainwright cuts target price to $18 from $27

* Fedex Corp : Daiwa Capital Markets raises target price to $285 from $272

* Gevo Inc : Jefferies raises target price to $1.4 from $0.6

* ServiceNow Inc : Raymond James initiates coverage with outperform rating

* ServiceNow Inc : Raymond James initiates coverage with price target $1,200

* Upstart Holdings Inc : Jefferies cuts target price to $77 from $80

* Vertex Pharmaceuticals Inc : Truist Securities cuts PT to $460 from $550

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment